Replies to post #419161 on Amarin Corp Plc (AMRN)

[rosemountbomber]

Jasbg, you are correct that GV is included in the statement that GV is not approved by the FDA for CV risk reduction. But the first statement:

That "Lovaza and its generics are not AB rated to prescription Vascepa" and the statement "In studies Lovaza and its generics failed to show CV benefit"

are referring to generics of Lovaza